Introduction: Why Demonstrating Peptide Sameness Is Analytically Challenging Establishing “sameness” for a traditional small-molecule generic drug generally involves confirming chemical […]
Which Analytical Techniques Are Needed to Prove Peptide Sameness in an ANDA Submission? Read More »
Introduction: When you decide to outsource peptide characterization, the quality of your results depends less on which CRO you choose
The modern pharmaceutical landscape is experiencing a significant transformation, moving beyond traditional low-molecular-weight compounds toward larger and more structurally sophisticated
The Regulatory Imperative for a Peptide Characterization CRO Deliverables Checklist A peptide characterization CRO deliverables checklist serves as a fundamental
Introduction: In peptide drug development, the quality of your analytical data is only as good as the reference standard anchoring
Introduction: Insulin analog characterization for generic ANDA is one of the most scientifically demanding challenges in the follow-on biologics space.
Introduction: Higher-order structure characterization of therapeutic peptides is no longer optional science — it is a regulatory and scientific imperative.
Introduction: The Critical Role of Peptide Aggregation Analysis in Biopharmaceutical Quality Peptide Aggregation Analysis is a critical regulatory and biophysical
Peptide Aggregation Analysis: SEC-MALS, DLS, and AUC for Detecting Aggregated Species Read More »
Introduction: Why Cyclic Peptide Characterization Requires a Distinct Analytical Framework Characterizing cyclic peptides is far more than a straightforward extension
Cyclic Peptide Characterization: LC-MS, NMR, and Structural Confirmation Strategies Read More »
Summary: 1: Introduction: Buprenorphine PLGA Depot Characterization is critical for the development of long-acting injectable formulations intended for opioid dependence
